Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination therapy refers to the standard medical treatment arm used in clinical research conducted by Assiut University for the management of diabetic peripheral neuropathy (DPN). The regimen consists of a vitamin B complex, alpha-lipoic acid, and a selective serotonin reuptake inhibitor (SSRI). Vitamin B complex (typically including B1, B6, and B12) is utilized to support neuronal metabolic processes and facilitate nerve repair. Alpha-lipoic acid acts as a potent antioxidant that mitigates oxidative stress-induced nerve damage and improves endoneurial blood flow. SSRIs are included to modulate central pain signaling pathways and address comorbid depressive symptoms often associated with chronic neuropathic pain. This multi-modal approach targets both the underlying metabolic pathophysiology and the symptomatic manifestations of peripheral nerve dysfunction in diabetic patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin B complex + alpha-lipoic acid + SSRI.